Published October 1987 | Version v1
Journal article Metadata-only

Radioimmunoassay of ferritin, CEA and prolactin for assessment of prognosis and efficacy of breast cancer therapy

Creators

  • 1. Nauchno-Issledovatel'skij Rentgeno-Radiologicheskij i Onkologicheskij Inst., Kiev (Ukrainian SSR)

Description

The levels of tumor markers - CEA, deritin and prolactin (the hormone of the anterior pituitary gland) were studied in the blood serum of 178 breast cancer patients in the menopause during combined therapy using a radioimmunoassay. This combination was shown to be informative for assessment of prognosis of disease and efficacy of antitumor therapy which was confirmed by clinical and x-ray findings and observation of a tumor process in breast cancer patients over a 5-year period

Additional details

Additional titles

Original title (Russian)
Радиоиммунологический анализ ферритина, раково-эмбрионального антигена и пролактина для оценки прогноза и эффективности лечения рака молочной железы

Publishing Information

Journal Title
Med. Radiol.
Journal Volume
32
Journal Issue
10
Series
Med. Radiol.
Journal Page Range
32-36
ISSN
0025-8334
CODEN
MERAA

INIS

Country of Publication
Russian Federation
Country of Input or Organization
USSR
INIS RN
19045328
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BLOOD SERUM; CARCINOEMBRYONIC ANTIGEN; EFFICIENCY; FERRITIN; FORECASTING; LTH; MAMMARY GLANDS; METASTASES; NEOPLASMS; PATIENTS; RADIOIMMUNOASSAY; RADIOTHERAPY; SURGERY
Descriptors DEC
ANTIGENS; BIOLOGICAL MATERIALS; BLOOD; BLOOD PLASMA; BODY; BODY FLUIDS; COMPLEXES; DISEASES; GLANDS; GONADOTROPINS; HORMONES; IMMUNOASSAY; IRON COMPLEXES; ISOTOPE APPLICATIONS; MATERIALS; MEDICINE; ORGANIC COMPOUNDS; ORGANS; PEPTIDE HORMONES; PITUITARY HORMONES; PROTEINS; THERAPY; TRACER TECHNIQUES; TRANSITION ELEMENT COMPLEXES